These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 33554363)

  • 41. Validation and performance comparison of three SARS-CoV-2 antibody assays.
    Paiva KJ; Grisson RD; Chan PA; Huard RC; Caliendo AM; Lonks JR; King E; Tang EW; Pytel-Parenteau DL; Nam GH; Yakirevich E; Lu S
    J Med Virol; 2021 Feb; 93(2):916-923. PubMed ID: 32710669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of various serological assays for novel SARS-COV-2.
    Sacristan MS; Collazos-Blanco A; Cintas MIZ; García AS; de Villavicencio CY; Maestre MM
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):963-968. PubMed ID: 33236270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Performance evaluation of microfluidic microplate-based fluorescent ELISA for qualitative detection of SARS-CoV-2-specific IgG and IgM.
    Kweon OJ; Yoon S; Choe KW; Kim H; Lim YK; Lee MK
    Sci Rep; 2024 Aug; 14(1):18200. PubMed ID: 39107336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Serological tests for SARS-CoV-2 in a health workers population in Nouakchott-Mauritania].
    Salem MLO; Sidiya MAMM; Eibih ABA; Maouloud MM; Ngaide BH; Dedy L; Hamza LM; Yacoub F
    Pan Afr Med J; 2021; 38():55. PubMed ID: 33854684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Performance of SARS-CoV-2 IgG and IgM Tests Using an Automated Chemiluminescent Assay.
    Zhou JA; Zeng HL; Deng LY; Li HJ
    Curr Med Sci; 2021 Apr; 41(2):318-322. PubMed ID: 33877548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Performance of the Abbott SARS-CoV-2 IgG serological assay in South African 2 patients.
    Jugwanth S; Gededzha MP; Mampeule N; Zwane N; David A; Burgers WA; Blackburn JM; Grove JS; George JA; Sanne I; Scott L; Stevens W; Mayne ES
    PLoS One; 2022; 17(2):e0262442. PubMed ID: 35120133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Generic, Scalable, and Rapid Time-Resolved Förster Resonance Energy Transfer-Based Assay for Antigen Detection-SARS-CoV-2 as a Proof of Concept.
    Rusanen J; Kareinen L; Szirovicza L; Uğurlu H; Levanov L; Jääskeläinen A; Ahava M; Kurkela S; Saksela K; Hedman K; Vapalahti O; Hepojoki J
    mBio; 2021 May; 12(3):. PubMed ID: 34006662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
    Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study.
    Schlesinger T; Weißbrich B; Wedekink F; Notz Q; Herrmann J; Krone M; Sitter M; Schmid B; Kredel M; Stumpner J; Dölken L; Wischhusen J; Kranke P; Meybohm P; Lotz C
    PLoS One; 2020; 15(11):e0242917. PubMed ID: 33232382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation.
    Jääskeläinen AJ; Kuivanen S; Kekäläinen E; Ahava MJ; Loginov R; Kallio-Kokko H; Vapalahti O; Jarva H; Kurkela S; Lappalainen M
    J Clin Virol; 2020 Aug; 129():104512. PubMed ID: 32563180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of SARS-CoV-2 antigen-based rapid diagnostic kits in Pakistan: formulation of COVID-19 national testing strategy.
    Saeed U; Uppal SR; Piracha ZZ; Rasheed A; Aftab Z; Zaheer H; Uppal R
    Virol J; 2021 Feb; 18(1):34. PubMed ID: 33581714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities.
    Orner EP; Rodgers MA; Hock K; Tang MS; Taylor R; Gardiner M; Olivo A; Fox A; Prostko J; Cloherty G; Farnsworth CW
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115300. PubMed ID: 33388575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.
    Hiki M; Tabe Y; Ai T; Matsue Y; Harada N; Sugimoto K; Matsushita Y; Matsushita M; Wakita M; Misawa S; Idei M; Miida T; Tamura N; Takahashi K; Naito T
    PLoS One; 2021; 16(4):e0249449. PubMed ID: 33822809
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.
    Al-Mughales JA; Al-Mughales TJ; Saadah OI
    Front Immunol; 2021; 12():705441. PubMed ID: 34539635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies.
    Gutiérrez-Cobos A; Gómez de Frutos S; Domingo García D; Navarro Lara E; Yarci Carrión A; Fontán García-Rodrigo L; Fraile Torres AM; Cardeñoso Domingo L
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):955-961. PubMed ID: 33236268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical assessment of the Roche SARS-CoV-2 rapid antigen test.
    Salvagno GL; Gianfilippi G; Bragantini D; Henry BM; Lippi G
    Diagnosis (Berl); 2021 Aug; 8(3):322-326. PubMed ID: 33554511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Time scale performance of rapid antigen testing for SARS-CoV-2: Evaluation of 10 rapid antigen assays.
    Abusrewil Z; Alhudiri IM; Kaal HH; El Meshri SE; Ebrahim FO; Dalyoum T; Efrefer AA; Ibrahim K; Elfghi MB; Abusrewil S; Elzagheid A
    J Med Virol; 2021 Dec; 93(12):6512-6518. PubMed ID: 34241912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients.
    Algaissi A; Alfaleh MA; Hala S; Abujamel TS; Alamri SS; Almahboub SA; Alluhaybi KA; Hobani HI; Alsulaiman RM; AlHarbi RH; ElAssouli MA; Alhabbab RY; AlSaieedi AA; Abdulaal WH; Al-Somali AA; Alofi FS; Khogeer AA; Alkayyal AA; Mahmoud AB; Almontashiri NAM; Pain A; Hashem AM
    Sci Rep; 2020 Oct; 10(1):16561. PubMed ID: 33024213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
    Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
    J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
    Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
    Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.